Tenderwize
Retour à la recherche

Accord de remise pour médicaments à base de métoprolol et hydrochlorothiazide

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Mar 27, 2027 · 126 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Metoprolol und Hydrochlorothiazid (C07BB22).

48/100

Score d'opportunité

Needs reviewHigh complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

48 / 100

Complexité

68 / 100

Facteurs de risque

No contract value, volumes, reimbursement forecast or minimum purchase commitment is disclosed, so the commercial oppor...

The buyer may replace the open-house agreement with exclusive rebate contracts, and the existing agreement may then end...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 27, 2027

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing the metoprolol and hydrochlorothiazide combination, classified under CPV 33600000.
  • Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V through an open-house model.
Afficher le résumé complet

Single-lot non-exclusive open-house rebate agreement for medicines containing metoprolol and hydrochlorothiazide (C07BB22) in Germany. The agreement is available to all eligible pharmaceutical companies on uniform, non-negotiable conditions without a selection decision. Contracts may be concluded during the term, initially from 1 June 2025 and no later than 31 May 2027, but may end earlier if exclusive rebate contracts enter into force. No contract value is stated. This is described as an open-house arrangement rather than a conventional public procurement award.

Risques

No contract value, volumes, reimbursement forecast or minimum purchase commitment is disclosed, so the commercial oppor...

The buyer may replace the open-house agreement with exclusive rebate contracts, and the existing agreement may then end...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The participant must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG, or a contractual association of pharmaceutical entrepreneurs, in relation to the...
  • A pharmaceutical entrepreneur placing medicines on the German market must have its registered office in Germany, another EU Member State, or another EEA contracting state.
  • A local representative may participate only if it is itself a pharmaceutical entrepreneur for the medicines offered.

Critères d'attribution

Lot 1

Price is identified as the award criterion; no description or numeric weighting is provided.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Metoprolol and Hydrochlorothiazide Rebate Agreement

Non-exclusive open-house rebate agreement under Section 130a(8) SGB V for medicines containing the active-ingredient combination metoprolol and hydrochlorothiazide (C07BB22). All eligible pharmaceutical companies may join under identical conditions; individual negotiations are generally not conducted. The agreement may be terminated or automatically end upon entry into force of exclusive rebate contracts.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Mar 27, 2027

Détails de la procédure

Date de publication
06 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
221763-2025

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy